
Avantor Inc. (AVTR) Stock Forecast & Price Target
Avantor Inc. (AVTR) Analyst Ratings
Bulls say
Avantor is a leading global provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. With a global footprint and diverse product portfolio, Avantor is well-positioned to benefit from growth in the life sciences industry. Additionally, recent management actions, such as the relaunch of vwr.com and a focus on operational improvements, have shown positive results and have the potential to drive further growth and margin expansion in the future. This, coupled with an expected market recovery in the biopharma and academic research sectors, supports a positive outlook on Avantor's stock.
Bears say
Avantor is facing several headwinds in its Laboratory Solutions and Bioscience Production segments, including declining organicsales, lower volumes, and a decline in adjusted operating income. Despite potential growth opportunities in the biopharma industry, the company's current performance and guidance do not inspire confidence in its ability to capitalize on these opportunities and return to positive organic growth in the near future. Additionally, investor concerns around its sustainability efforts could weigh on the stock's performance.
This aggregate rating is based on analysts' research of Avantor Inc. and is not a guaranteed prediction by Public.com or investment advice.
Avantor Inc. (AVTR) Analyst Forecast & Price Prediction
Start investing in Avantor Inc. (AVTR)
Order type
Buy in
Order amount
Est. shares
0 shares